Products are shown once even when a blend contains several tracked components. Each card distinguishes flat all-dose pricing, dose-dependent pricing, and starting-price-only offers so a low entry price is not mistaken for a high-dose price. Dose and strength details are provider-stated catalog information, not dosing advice.
A current product surface and active public access path establish that the product is listed.
Current cost
$249.00/month total
Price behavior
Price changes by dose
Subscription
No separate subscription
Certificate of analysis
No public COA located
Available dosage / strength
Subcutaneous NAD+ injection marketed as one 1,000 mg vial, 30 provider-labeled doses and a 30-day supply; current Shopify body copy instead describes a B12/lipotropic blend.
Dose or option
Supply
Current price
Source
One-time 30-day supply
Subcutaneous NAD+ injection marketed as one 1,000 mg vial, 30 provider-labeled doses and a 30-day supply; current Shopify body copy instead describes a B12/lipotropic blend.
Subcutaneous NAD+ injection marketed as one 1,000 mg vial, 30 provider-labeled doses and a 30-day supply; current Shopify body copy instead describes a B12/lipotropic blend.
Subcutaneous NAD+ injection marketed as one 1,000 mg vial, 30 provider-labeled doses and a 30-day supply; current Shopify body copy instead describes a B12/lipotropic blend.
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $199.00 and $249.00 per month. We display the higher $249.00 amount and exclude it from lowest-price rankings.
Current cost
$249.00/month total
Price behavior
Price changes by dose
Subscription
No separate subscription
Certificate of analysis
No public COA located
Available dosage / strength
Monthly low-dose semaglutide injection up to 1 mg/week; exact vial configuration is not public.
Dose or option
Supply
Current price
Source
Monthly Lite program
Monthly low-dose semaglutide injection up to 1 mg/week; exact vial configuration is not public.
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $215.00 and $249.00 and $299.00 and $399.00 per documented billing option. We display the higher $399.00 amount and exclude it from lowest-price rankings.
Current cost
$399.00 per documented billing option; higher provider price shown
Price behavior
Not publicly comparable
Subscription
No separate subscription
Certificate of analysis
No public COA located
Available dosage / strength
Current semaglutide Select program; exact strength and dispensed quantity are not public.
Dose or option
Supply
Current price
Source
Current Select and standard-program price conflict
Current semaglutide Select program; exact strength and dispensed quantity are not public.
$399.00 per documented billing option (higher provider price shown; provider also lists $215.00 or $249.00 or $299.00)
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $299.00 and $332.33 and $349.00 and $997.00 per documented billing option. We display the higher $997.00 amount and exclude it from lowest-price rankings.
Current cost
$997.00 per documented billing option; higher provider price shown
Price behavior
Not publicly comparable
Subscription
No separate subscription
Certificate of analysis
No public COA located
Available dosage / strength
Current page metadata identifies Tirzepatide Lite while rendered body copy overlaps the microdose and standard programs; exact product scope is unresolved.
Dose or option
Supply
Current price
Source
Current Tirzepatide Lite identity/package conflict
Current page metadata identifies Tirzepatide Lite while rendered body copy overlaps the microdose and standard programs; exact product scope is unresolved.
$997.00 per documented billing option (higher provider price shown; provider also lists $299.00 or $332.33 or $349.00)
A current product surface and active public access path establish that the product is listed.
Provider price discrepancy: current provider pages list $275.00 and $299.00 and $349.00 and $499.00 per documented billing option. We display the higher $499.00 amount and exclude it from lowest-price rankings.
Current cost
$499.00 per documented billing option; higher provider price shown
Price behavior
Not publicly comparable
Subscription
No separate subscription
Certificate of analysis
No public COA located
Available dosage / strength
Current tirzepatide Select program; exact strength and dispensed quantity are not public.
Dose or option
Supply
Current price
Source
Current Select and standard-program price conflict
Current tirzepatide Select program; exact strength and dispensed quantity are not public.
$499.00 per documented billing option (higher provider price shown; provider also lists $275.00 or $299.00 or $349.00)